BELLUS Health Inc Stock Toronto S.E.
Equities
CA07987C1059
Biotechnology & Medical Research
Sales 2021 | 16K 11.7K | Sales 2022 | 16K 11.7K | Capitalization | 1.03B 756M |
---|---|---|---|---|---|
Net income 2021 | -71M -51.9M | Net income 2022 | -76M -55.55M | EV / Sales 2021 | 36,461 x |
Net cash position 2021 | 248M 181M | Net cash position 2022 | 336M 245M | EV / Sales 2022 | 43,652 x |
P/E ratio 2021 |
-8.96
x | P/E ratio 2022 |
-12.4
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 81.52% |
Managers | Title | Age | Since |
---|---|---|---|
Roberto Bellini
CEO | Chief Executive Officer | 44 | 09-06-04 |
Jeremy Martin
PSD | President | - | - |
Chairman | 77 | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 77 | 01-12-31 | |
Franklin Berger
BRD | Director/Board Member | 74 | 10-04-30 |
Director/Board Member | 52 | 09-05-31 |
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |